Skip to search formSkip to main contentSkip to account menu

National drug codes - CodeSystem

Known as: National drug codes 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness
To describe utilization of filgrastim and infliximab, the first two products with biosimilars approved in the United States. 
Review
2019
Review
2019
Review of purchases of unapproved medications by the Veterans Health Administration.
PURPOSE Many medications that were marketed prior to 1962 but lack Food and Drug Administration (FDA) approval are prescribed in… 
2019
2019
Number of manufacturers and generic drug pricing from 2005 to 2017.
OBJECTIVES To evaluate how changes in generic drug prices and the incidence of abrupt price increases varied with the number of… 
2017
2017
The Impact of Depression and Use of Anti-Depressants on Healthcare Resource Utilization (HCRU) in Multiple Myeloma (MM) Patients
Objectives Depression and the use of anti-depressants are common co-existing morbidities often encountered by MM patients… 
2015
2015
Common Models, Different Approaches
In recent years, a number of initiatives have established database networks for studying drug safety, including the Mini-Sentinel… 
2015
2015
Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm
OBJECTIVE To investigate approaches to supporting the analysis of historical medication datasets with RxNorm. METHODS We… 
2010
2010
C-C4-03: Examination of the Use of First-Line Chemotherapy Regimens for Colorectal and Lung Cancer: Impact of Patient Characteristics
Background: Chemotherapy has been shown to improve both response and survival rates for patients with cancer. As chemotherapy… 
2010
2010
PMS20 A COMPARISON OF DIFFERENT METHODS OF ESTIMATING FRACTURE RISK AND FRACTURE RISK REDUCTION IN COST-EFFECTIVENESS ANALYSES OF THE OSTEOPOROSIS TREATMENT BAZEDOXIFENE
s A67 model (fi ve-year horizon, three-month cycles) evaluating NSAID treatment in OA, the overall AE related costs and their… 
2010
2010
CMS says states can exempt hospitals from NDC-reporting requirements
State Medicaid programs no longer need to require the reporting of National Drug Codes (NDCs) on claims involving certain drugs… 
Review
1998
Review
1998
Comparison and Analysis of the National Drug Code Systems Among Drug Information Databases
National Drug Codes (NDC) is a drug identification code that is widely used to identify each unique commercially available drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)